The notices it replaced
- Reissues: PA-23-233 PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- 2 steps back: PA-22-179 PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- 3 steps back: PA-21-261 PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- 4 steps back: PA-20-261 PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- 5 steps back: PA-19-271 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required
- 6 steps back: PA-18-576 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
Replaced by PA-27-102.
Who won it before
100 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $43,343,797 in first-year total cost, median $345,708.
Most frequent study sections
- Special Emphasis Panel[ZRG1 CCHI-J (10)]13
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]8
- Special Emphasis Panel[ZRG1 RPHB-D (16)]7
- Special Emphasis Panel[ZRG1 SCIL-D (10)]6
- Special Emphasis Panel[ZRG1 BP-C (10)]5
Most frequent institutions
- HEALTH BEHAVIOR SOLUTIONS, INC.3
- KLEIN BUENDEL, INC.3
- COG ANALYTICS, LLC2
- FRD ACCEL, LLC2
- INHERET, INC2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer2R42CA268623-02 · under PA-23-233 | DING, KAIKAKADE, SANDEEPVISWANATHAN, AKILA | NANOCAN THERAPEUTICS CORPORATION, NJ | $998,781 | ZRG1 |
| 2025 | Doxy.me VR: A scalable virtual reality app to facilitate evidence-based immersive telemental health2R44MH129065-03 | BUNNELL, BRIAN E.ONG, TRITON | DOXY.ME, LLC, SC | $744,020 | ZRG1 |
| 2025 | Improving adherence and outcomes in evidence-based treatment for OCD: Type I Effectiveness-Implementation RCT and Scaled Development of OC-Go, a crowdsourced interactive patient-provider tool1R42MH142197-01 | MCGUIRE, JOSEPHPIACENTINI, JOHN C.TUERK, PETER | VIRTUALLYBETTER HEALTH LLC, VA | $449,958 | ZMH1 |
| 2025 | Developing virtual reality programs to address social skills deficits in youth with ADHD1R43MH140643-01 | MILLER, KEVINWOOD, ZEBULUN MAXWELL | OPENMINDXR LLC, IN | $449,729 | ZRG1 |
| 2025 | Interactive E-Learning for Therapist Training in Exposure Therapy1R41MH139194-01 · under PA-23-233 | BENITO, KRISTEN GKEMP, JOSHUA | PARC INNOVATIONS LLC, RI | $442,074 | ZRG1 |
| 2025 | Transforming prostate cancer diagnosis: Feasibility testing of a novel system for integrated endorectal MRI and in-bore biopsy1R41CA278032-01A1 | COAKLEY, FERGUS VDUFRESNE, ROBERT DUFFY | OMNECOIL INSTRUMENTS, INC., OR | $399,995 | ZRG1 |
| 2025 | Project GAME ON!: Empowering urban children to engage in healthy behaviors to reduce obesity risk through an interactive digital comic tool1R41MD020611-01A1 | LEUNG, MAY MAYPLATKIN, CHARLES | POPCOM HEALTH INC, MA | $396,605 | ZMD1 |
| 2025 | Aortic dissection flap division by novel electrosurgical catheter facilitates aortic endograft landing zones1R41HL178190-01 · under PA-23-233 | BERGUER, RAMONELIASON, JONATHAN LEE | CUTCATH LLC, MI | $395,306 | ZRG1 |
| 2025 | Indigo Eyewear for Treating Myopia Progression1R43EY038143-01 | GRYTZ, RAFAELPUCKER, ANDREW D | ELECTRIC INDIGO, LLC, AL | $356,807 | ZEY1 |
| 2025 | Evaluation of a novel soil-derived Mycobacterium as a nutritional supplement to promote stress resilience2R42AT011390-03 | LOWRY, CHRISTOPHER ASTAMPER, CHRISTOPHER E | KIOGA INC., CO | $335,257 | ZAT1 |
| 2025 | Study of Transcutaneous Auricular Neurostimulation as a Treatment for Alcohol Use Disorder1R41AA032157-01 · under PA-23-233 | KHODAPARAST, NAVIDOH, HYUNTAEK | SPARK BIOMEDICAL INC, TX | $305,545 | ZRG1 |
| 2025 | AI-Based Speech Enhancement for Hearing Aids1R41DC023169-01 | BIRKHIMER, CRAIGHOOVER, ERIC C | OMNISPEECH, LLC, MD | $292,543 | ZDC1 |
| 2025 | Overcoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell Biotherapeutic1R42CA302331-01 | MITCHELL, DUANE A.RODRIGUEZ, EDGARDO | IONCOLOGI INC, FL | $276,544 | ZRG1 |
| 2025 | Life at 100.4: An Immersive Social Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers1R41NR022239-01 · under PA-23-233 | MARKS, ASHER | THE GLIMPSE GROUP, INC., NY | $225,609 | ZRG1 |
| 2024 | BabyStrong II (Stimulating the Tragus for Neural Growth): A Randomized Controlled Trial of taVNS-Paired Bottle Feeding to Improve Oral Feeding2R42HD104409-02 · under PA-23-233 | JENKINS, DOROTHEA DENISERUSCITO, JOE | FRD ACCEL, LLC, SC | $1,039,456 | ZRG1 |
| 2024 | ConnectedNest: a digital platform connecting individuals with cancer to social care1R42CA295106-01 · under PA-23-233 | HAYNES, DAVID A | XANTHOSHEALTH, INC., MN | $954,983 | ZRG1 |
| 2024 | NGS based metagenomic screening of ocular infections2R42EY033266-02 · under PA-23-233 | KYUBWA, ESPOIRVAN GELDER, RUSSELL N. | CHROMOLOGIC, LLC, CA | $803,560 | ZRG1 |
| 2024 | Real-world translation of a dynamic and personalized intervention for shift workers2R42HL163783-02 · under PA-23-233 | WALCH, OLIVIA | ARCASCOPE, INC, VA | $693,433 | ZRG1 |
| 2024 | VoiceLove: NICU Utilization of Remote voice Technology to improve mateRnal Experience (NURTURE)1R42MH135602-01 · under PA-22-179 | OSMUNDSON, SARAH SCHEIDERICH | VOICELOVE LLC, NY | $495,248 | ZRG1 |
| 2024 | Circumventing the pharmacokinetic/pharmacodynamic limitations of antioxidant therapy for Parkinson's Disease by nose to brain delivery of N-acetylcysteine1R41AG087860-01 · under PA-23-233 | GREENE, DOUGLASVU, AN T | NEURONASAL INC, PA | $478,165 | ZRG1 |
| 2024 | Engagement and clinical impact of the Teleo virtual therapy platform in clinical settings1R42MH136878-01 · under PA-23-233 | HONG, DAVID SKUHN, ERIC ROLAND | MAINSQUARE CO, CA | $424,754 | ZRG1 |
| 2024 | Enhancing pain management for knee replacement patients through an innovative non-invasive and opioid-sparing device1R41DA059303-01A1 · under PA-23-233 | CHELLY, JACQUES E.SADHASIVAM, SENTHILKUMAR | NCAP MEDICAL, LLC, UT | $416,443 | ZRG1 |
| 2024 | Assessment of a Digitally Controlled Aerosolized Nicotine Replacement Therapy1R42DA060773-01 · under PA-23-233 | DAVIS, JAMES M | PREDICTABLY HUMAN, INC., CT | $399,989 | ZRG1 |
| 2024 | Efficacy of a culturally-sensitive telehealth platform in fostering community-based care coordination for respectful maternal mental health1R41NR021628-01 · under PA-22-179 | KAMARA, MOHAMED | INOVCARES CONNECTED COMPREHENSIVE HEALTHCARE CORPORATION, MD | $360,358 | ZRG1 |
| 2024 | Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation1R42HD116627-01 · under PA-23-233 | BREITENSTEIN, SUSAN M | KLEIN BUENDEL, INC., CO | $346,573 | ZRG1 |
| 2024 | Anise Health: Culturally-Sensitive Digital Mental Health for Asian Americans1R41MH134727-01A1 · under PA-23-233 | KEUM, BRIAN TAEHYUKZHANG, ALICE | ANISE HEALTH INC, DE | $311,413 | ZRG1 |
| 2024 | mVOR: An mHealth Approach to the Clinical Assessment of Gaze Stability and Telerehabilitation of Vestibular Dysfunction1R41DC022209-01 · under PA-23-233 | AHAMED, SHEIKH IQBAL | UBITRIX INTERNATIONAL, INC., WI | $305,788 | ZRG1 |
| 2024 | Novel Digital Health Platform with Virtual Health Coach for Improving Perioperative Patient Outcomes and Care Coordination1R42HL174371-01A1 · under PA-23-233 | HOLDER-MURRAY, JENNIFERKALUHIOKALANI, KATHYMAHAJAN, AMAN | PIP CARE, INC., NY | $302,049 | ZRG1 |
| 2024 | Digitalization of a Multicomponent Family-Based Behavioral Intervention (Digital Wellness Nurse - FIT Families) for African American Adolescents with Obesity1R41MD018558-01 · under PA-22-179 | MCCLENDON, JEROME L | MACHINE AND HUMAN INTERACTION LLC., SC | $299,573 | ZRG1 |
| 2024 | Clinical testing of Listeria-TT and Gemcitabine in a Phase I clinical trial with PDAC patients1R42CA287679-01 · under PA-22-179 | BRADLEY, CHRISGRAVEKAMP, CLAUDIAKUANG, CHAOYUANMCAULIFFE, JOHN | LOKI THERAPEUTICS, INC, NY | $294,962 | ZRG1 |
| 2024 | A scalable intervention for stress management practices1R41AT012854-01 · under PA-23-233 | AGUIRRE, MILTON | LIVOTION LLC, IN | $294,312 | ZRG1 |
| 2024 | Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer1R42HG013908-01 · under PA-23-233 | SNIR, MORAN | NEST GENOMICS, CA | $291,643 | ZRG1 |
| 2024 | An AI-driven total parenteral nutrition platform for cost-effective and scientifically personalized nutrition for premature newborns1R42HD115517-01 · under PA-23-233 | AGHAEEPOUR, NIMAPHONGPREECHA, THANAPHONG | TAKEOFF41, INC., CA | $291,523 | ZRG1 |
| 2024 | SimuVersity Medical Center: Pain and opioid management training in diverse patient populations1R41DA059281-01A1 · under PA-23-233 | BORCKARDT, JEFFREY J | PALMETTO INNOVATIVE EDUCATION, LLC, SC | $290,134 | ZRG1 |
| 2024 | Treating Balance Impairment of the Elderly with TMS-induced Brain Connectivity1R41AG085838-01A1 · under PA-23-233 | PARIKH, PRANAV J | WEINBERG MEDICAL PHYSICS, LLC, MD | $100,000 | ZRG1 |
| 2023 | 2-HOBA for Treatment of Pulmonary Hypertension2R42HL158393-02 · under PA-22-179 | RATHMACHER, JOHN AWEST, JAMES D | MTI BIOTECH, INC., IA | $1,173,060 | ZRG1 |
| 2023 | BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline2R42AG071290-02 · under PA-22-179 | HALTER, RYAN JOSEPH | SYNCHROHEALTH LLC, NH | $919,218 | ZRG1 |
| 2023 | An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide2R42MH125691-02 · under PA-21-261 | FEUERSTEIN, SETHSIMON, PATRICIA | OUI THERAPEUTICS, INC, CT | $766,481 | ZRG1 |
| 2023 | Making Mindfulness-Based Cognitive Therapy accessible for underserved pregnant people: Developing Center M for commercialization1R41MH134692-01A1 · under PA-22-179 | TILDEN, ELLEN LANE | CENTER MOM, INC., OR | $416,322 | ZRG1 |
| 2023 | A cloud-based digital health navigation program for colorectal cancer screening1R42CA275665-01A1 · under PA-22-179 | MILLER, DAVID P | DIGITAL HEALTH NAVIGATION SOLUTIONS, LLC, NC | $397,979 | ZRG1 |
| 2023 | A Self-Guided Mobile Intervention for Adults with Binge Eating and Obesity1R41MH134704-01 · under PA-22-179 | FEUERSTEIN, SETHGRAHAM, ANDREA KASSMANASSE, STEPHANIESIMON, PATRICIA | OUI THERAPEUTICS, INC, CT | $375,273 | ZRG1 |
| 2023 | Digital clinical hypnosis for chronic pain management1R41AT011996-01A1 · under PA-22-179 | JENSEN, MARK P | HYPNOSCIENTIFIC, INC., NY | $324,568 | ZRG1 |
| 2023 | A Mobile-Delivered Personalized Feedback Intervention for Black Individuals who Engage in Hazardous Drinking1R41AA031398-01 · under PA-22-179 | BROWN, RICHARD AZVOLENSKY, MICHAEL J. | HEALTH BEHAVIOR SOLUTIONS, INC., TX | $275,550 | ZRG1 |
| 2023 | An adjustable stiffness orthosis to maintain muscle engagement and push-off power in cerebral palsy.1R41HD113494-01 · under PA-22-179 | LERNER, ZACHARY FOREST | BIOMOTUM, LLC, OR | $274,282 | ZRG1 |
| 2023 | Impact VR: An Emotion Recognition and Regulation Training Program for Youth with Conduct Disorder1R41MH133540-01 · under PA-22-179 | THOMSON, NICHOLAS DAVIDVRANA, SCOTT R. | ARCHE VR LLC, VA | $210,467 | ZRG1 |
| 2023 | Developing a virtual reality guided acupuncture imagery treatment for Chronic low back pain1R41AT011822-01A1 · under PA-22-179 | KONG, JIAN | MASSACHUSETTS NEURO TECHNOLOGY, INC., MA | $140,605 | ZRG1 |
| 2022 | MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation2UT2CA244056-02 · under PA-21-261 | CHATTERJEE, ARITRICKFAN, XIAOBINGKARCZMAR, GREGORY S.OTO, AYTEKIN | QMIS, LLC, IL | $1,024,503 | ZRG1 |
| 2022 | STING Activators as Therapy for Cancer2R42CA250629-02A1 · under PA-21-261 | AHN, JEONGHYUNBARBER, GLEN NRAMOS, JUAN CARLOS | STINGINN, LLC, FL | $993,220 | ZRG1 |
| 2022 | Translating an In-Person Brief, Bystander Bullying Intervention (STAC) to a Technology-Based - Phase II2R42MD014943-02A1 · under PA-21-261 | MIDGETT, AIDA | KLEIN BUENDEL, INC., CO | $962,564 | ZRG1 |
| 2022 | Development and Randomized Clinical Trial of an App-based Intervention to Reduce Postpartum Depression in High-Risk Women2R44MH112216-02 · under PA-21-261 | FOX, DEBRA LPOLESHUCK, ELLEN L | FOX LEARNING SYSTEMS, INC., PA | $870,193 | ZRG1 |
| 2022 | Radio-immunotherapy dose-painting (RAID) treatment for hormonal resistant prostate cancer1R42CA272056-01 · under PA-21-261 | NGWA, WILFREDSHILLING, ADAM | NANOCAN THERAPEUTICS CORPORATION, NJ | $399,680 | ZRG1 |
| 2022 | Simulated Exposure Trainer (SET-VR): Implementing Targeted Experiential Training with a Virtual Patient1R41MH131229-01 · under PA-21-261 | ADAMS LARSEN, MARGOKEMP, JOSHUA | VIRTUALLY BETTER, INC., GA | $368,689 | ZRG1 |
| 2022 | NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait1R41HD111289-01 · under PA-21-261 | KRISHNAN, CHANDRAMOULI | ELITE ATHLETE PRODUCTS INC, CA | $344,843 | ZRG1 |
| 2022 | Targeting OSCC cells with a lozenge to treat oral cancer1R41CA268160-01A1 · under PA-21-261 | GOLDBERG, GARY | SENTRIMED, INC., NJ | $322,833 | ZRG1 |
| 2022 | Assessment of a Microprocessor Ankle for Low Mobility Individuals with Amputation1R41HD110987-01 · under PA-21-261 | LAWSON, BRIAN EDWARD | SYNCHRO MOTION, LLC, TN | $276,629 | ZRG1 |
| 2022 | An Interactive Education Program to Reduce High Risk Behavior in Adolescents1R42HD110333-01 · under PA-21-261 | HOUCK, CHRISTOPHER D. | KLEIN BUENDEL, INC., CO | $266,092 | ZRG1 |
| 2022 | Clinical effectiveness of a wearable hydration device1R42AG080886-01 · under PA-21-261 | JOHNSON, EAMONPIKTEL, JOSEPHROACH, MARY JOAN | TRITONX INC., IL | $259,939 | ZRG1 |
| 2022 | Brief Personalized Feedback Intervention for Latinx Hazardous Drinkers: A Community-Based Intervention1R41AA030227-01 · under PA-21-261 | BROWN, RICHARD AZVOLENSKY, MICHAEL J. | HEALTH BEHAVIOR SOLUTIONS, INC., TX | $259,522 | ZRG1 |
| 2022 | Reusable, transparent, and reconfigurable N95-equivalent Respirator Masks: design, fabrication, and trials for enhanced adoption1R41DC020133-01A1 · under PA-21-261 | CHEN, ZICHUN, ALICE | SEEUS95 INC, NY | $259,505 | ZRG1 |
| 2022 | FASTT telehealth behavioral support service for caregivers of children with developmental delay or disability1R41HD111097-01 · under PA-21-261 | PEAKE, SHANNON JZIMMERMAN, STEPHEN JOHN | SPECIAL X INC., CA | $252,262 | ZRG1 |
| 2022 | Respiratory Biofeedback Sensor for Yoga Practice for Youth with Chronic Pain.1R41AT012155-01 · under PA-21-261 | RAHMAN, TARIQ | CREATIVE MICRO DESIGNS, INC., DE | $170,256 | ZRG1 |
| 2021 | Brillouin optical eye scanner prototypes for commercialization2R42EY028820-02 · under PA-20-261 | CHERNYAK, DIMITRIYUN, SEOK-HYUN ANDY | INTELON OPTICS, INC., MA | $654,974 | ZRG1 |
| 2021 | Family Supportive Supervisor Training and Workplace Assessment Tool2R42AG050347-02A1 · under PA-19-271 | KOSSEK, ELLEN ERNST | WORK LIFE HELP, INC., MI | $471,990 | ZRG1 |
| 2021 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy1R42CA265316-01 · under PA-20-261 | HETTS, STEVEN WILLIAM | FILTRO MEDICAL INC., CA | $400,000 | ZRG1 |
| 2021 | Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma1R42CA257797-01 · under PA-19-271 | SHOKEEN, MONICA | SARYA, LLC, MO | $398,858 | ZRG1 |
| 2021 | Leveraging an academic-industry partnership to develop a cancer-specific mobile meditation app1R41CA261260-01 · under PA-20-261 | HUBERTY, JENNIFER LYNNE | CALM.COM, INC., CA | $397,657 | ZRG1 |
| 2021 | PRANAYAMA BASED GROUP VIDEO APP FOR CANCER SURVIVORSHIP. Phase I. Breast Cancer Pilot1R41CA254557-01A1 · under PA-19-271 | BALASUBRAMANIAN, SUNDARAVADIVEL | PRANASCIENCE INSTITUTE LLC, SC | $388,724 | ZRG1 |
| 2021 | Development and Evaluation of a Brief Behavioral Activation Mobile Application for Nicotine Vaping Cessation Among Adolescent Primary Care Patients1R41DA053856-01 · under PA-20-261 | DAHNE, JENNIFER RENEE | MOUNTAINPASS TECHNOLOGY, LLC, MD | $320,000 | ZRG1 |
| 2021 | Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use1R42DA054784-01 · under PA-20-261 | JACOBS, CINDYRIGOTTI, NANCY A | ACHIEVE LIFE SCIENCES, INC., WA | $320,000 | ZRG1 |
| 2021 | BabyStrong taVNS-Paired BottleFeeding to Improve Oral Feeding1R41HD104409-01A1 · under PA-20-261 | JENKINS, DOROTHEA DENISE | FRD ACCEL, LLC, SC | $318,713 | ZRG1 |
| 2021 | Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth1R42HD107747-01 · under PA-20-261 | DILLINGHAM, TIMOTHY R | IFIT PROSTHETICS, LLC, WI | $292,648 | ZRG1 |
| 2021 | Multi-Modal Fingertip Sensors for Prosthetic Hand Control and Feedback1R41EB032723-01 · under PA-20-261 | SEGIL, JACOB | POINT DESIGNS, LLC, CO | $276,835 | ZRG1 |
| 2021 | Disseminable Evidence-Based Treatment for the Dental Office: Virtual Exposure Tools for Dental Fear - neVR Fear the Dentist1R42DE030040-01 · under PA-19-271 | ADAMS LARSEN, MARGOHEYMAN, RICHARD ELIOTSLEP, AMY MICHELE SMITH | VIRTUALLY BETTER, INC., GA | $264,997 | ZRG1 |
| 2021 | Rehabilitation Using Community-Based Affordable Robotic Exercise Systems (Rehab CARES)1R42HD104325-01A1 · under PA-20-261 | JOHNSON, ALWYN P.JOHNSON, MICHELLE J. | RECUPERO ROBOTICS LLC, PA | $256,603 | ZRG1 |
| 2021 | Mindfulness Based Stress Reduction Application for African American Caregivers1R41AG071168-01A1 · under PA-20-261 | ALEXANDER, KARENCARSWELL, STEVEN BERNARD | COG ANALYTICS, LLC, MD | $251,841 | ZRG1 |
| 2020 | Personalized dosing of dichloroacetate for the treatment of rare and common diseases2R42HD089804-04 · under PA-19-271 | STACPOOLE, PETER WALLACE | MEDOSOME BIOTEC, LLC, FL | $1,000,000 | ZRG1 |
| 2020 | InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.2R42CA239842-02A1 · under PA-19-271 | KEREN, DAVID FREEMAN | INHERET, INC, MI | $993,562 | ZRG1 |
| 2020 | Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL1R42CA254685-01 · under PA-19-271 | BERGER, MARK SGEYER, MARK B | ACTINIUM PHARMACEUTICALS, INC., NY | $378,389 | ZRG1 |
| 2020 | Clinical feasibility of a non-invasive, low-cost wearable for measuring air trapping in COPD1R41HL152769-01A1 · under PA-19-271 | ARTUNDUAGA, MARIA | SAMAY, INC., CA | $350,000 | ZRG1 |
| 2020 | Non-Invasive Imaging of Oral Cavity Cancer1R42CA254776-01A1 · under PA-19-271 | BRAND, CHRISTIANPATEL, SNEHALREINER, THOMAS | SUMMIT BIOMEDICAL IMAGING, LLC, NY | $262,732 | ZRG1 |
| 2020 | FES-Rowing: Preventing the Secondary Conditions of Paralysis Through Vigorous Exercise1R41HD102267-01A1 · under PA-19-271 | BELLMAN, MATTHEW JOHNTAYLOR, J ANDREW | MYOLYN, LLC, FL | $212,235 | ZRG1 |
| 2019 | Clinical validation and commercialization of a novel hydrogel-based vaginal packing system for pelvic brachytherapy2R42CA203171-02A1 · under PA-18-576 | SHOWALTER, TIMOTHY NORMAN | BRACHYFOAM, LLC, VA | $770,412 | ZRG1 |
| 2019 | Automated point-of-care identification of innocent Still's murmur in children2R42HL131081-02 · under PA-18-576 | DOROSHOW, ROBINSHEKHAR, RAJ | AUSCULTECH DX, LLC, MD | $764,643 | ZRG1 |
| 2019 | MISSION U: A MULTIMEDIA TRAINING TOOL FOR TREATING INDIVIDUALS WITH CO-OCCURRING MENTAL HEALTH AND SUBSTANCE USE DISORDERS2R42AA026751-02 · under PA-18-576 | SMELSON, DAVID A | PRAXIS, INC., MA | $751,223 | ZRG1 |
| 2019 | Online Training For Addressing Perinatal Depression2R42MH113381-02 · under PA-18-576 | BYATT, NANCYMOORE SIMAS, TIFFANY ANNE | PRAXIS, INC., MA | $746,903 | ZRG1 |
| 2019 | Continuing Care App for Probationers and Parolees with Substance Use Disorders2R44MD008848-02 · under PA-18-576 | CARSWELL, STEVEN BERNARDGORDON, MICHAEL SCOTT | COG ANALYTICS, LLC, MD | $546,245 | ZRG1 |
| 2019 | Evolution of an Adaptable Prosthetic Foot Design for Normalization of Biomechanics During Community Participation2R42HD093476-02A1 · under PA-18-576 | COLVIN, JAMES | OHIO WILLOW WOOD COMPANY, OH | $449,359 | ZRG1 |
| 2019 | High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators1R41HG010638-01 · under PA-18-576 | LYNCH, KRISTEN WYEAKLEY, JOANNE MULLIGAN | BIOSPYDER TECHNOLOGIES, INC., CA | $349,024 | ZRG1 |
| 2019 | InheRET: A SaaS solution to identifying patients at increased risk for hereditary disease1R41CA239842-01 · under PA-18-576 | KEREN, DAVID FREEMAN | INHERET, INC, MI | $299,828 | ZRG1 |
| 2019 | Increasing Access and Developing Predictors for Colorectal Cancer Screening for Minority and Medicaid Clients1R41CA232824-01A1 · under PA-18-576 | ERWIN, DEBORAH OJOHNSON, DEE D | WITNESS CARES, LLC, NY | $296,546 | ZRG1 |
| 2019 | Custom-Fit Personal Sound Amplification Smartphone Application1R41DC017939-01 · under PA-18-576 | RUNGE, CHRISTINA L | ASCENDING HEARING TECHNOLOGIES, LLC, WI | $263,677 | ZRG1 |
| 2019 | Development of a Neonatal Jaundice Treatment Accelerator by Circumferential Redirection of Unused Phototherapy Light onto the Infants Untreated Skin Surface1R41HD093478-01A1 · under PA-18-576 | SLUSHER, TINA MARYE | ARBOR GRACE, INC., MI | $229,235 | ZRG1 |
| 2019 | Me & You-Tech: A socio-ecological solution to teen dating violence for the digital age.1R42HD100233-01 · under PA-18-576 | MCLAUGHLIN, JEFFERYPESKIN, MELISSASHEGOG, ROSS | RADIANT CREATIVE GROUP, LLC, TX | $225,000 | ZRG1 |
| 2019 | Culturally sensitive, evidence-based, Spanish language mobile app for smoking cessation for Latino cigarette smokers1R41DA048692-01 · under PA-18-576 | BROWN, RICHARD AZVOLENSKY, MICHAEL J. | HEALTH BEHAVIOR SOLUTIONS, INC., TX | $224,989 | ZRG1 |
| 2019 | Mitigation of Radiation Therapy Induced Neuroinflammation and Cognitive Dysfunction1R42CA236382-01 · under PA-18-576 | SREDNI, SIMONE TREIGERWINDISCH, MANFRED | IMMUNOCHEM THERAPEUTICS, LLC, MA | $224,888 | ZRG1 |
| 2019 | The Point Digit: A ratcheting prosthetic finger using advanced rapid manufacturing technology1R42HD097827-01A1 · under PA-18-576 | WEIR, RICHARD FERGUS FFRENCH | POINT DESIGNS, LLC, CO | $224,150 | ZRG1 |
| 2019 | MoodRing: A multi-stakeholder platform to monitor and manage adolescents' depression in primary care with passive mobile sensing.1R44MH122067-01 · under PA-18-576 | DORYAB, AFSANEHRADOVIC-STAKIC, ANASHAABAN, SAMI | NURELM E-BUSINESS SOFTWARE, PA | $223,419 | ZRG1 |
| 2018 | Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care2R42HD088325-02A1 · under PA-18-576 | ARONSON, IAN DAVID | DIGITAL HEALTH EMPOWERMENT, INC., NY | $477,293 | ZRG1 |
| 2018 | Making Standing Balance The Fifth Vital Sign in Clinical Settings1R42AG062065-01 · under PA-18-576 | BERME, NECIP | BERTEC CORPORATION, OH | $275,801 | ZRG1 |
| 2018 | Surefooted Fall Simulation Training1R41AG057285-01A1 · under PA-18-576 | JAYAKUMAR, UDAI | SUREFOOTED, LLC, IL | $222,737 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.